Monte Rosa Therapeutics (GLUE) Asset Utilization Ratio (2024 - 2026)

Monte Rosa Therapeutics' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.01 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 98.11% year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (down 98.11% YoY), while the FY2025 annual figure was 0.28, up 36.83% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.01, down from 0.64 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.78 in Q2 2025, with the low at 0.0 in Q1 2024.
• The 3-year median for Asset Utilization Ratio is 0.2 (2024), against an average of 0.27.
• The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio jumped 10179.04% in 2025, then plunged 98.11% in 2026.
• Monte Rosa Therapeutics' Asset Utilization Ratio stood at 0.2 in 2024, then jumped by 216.61% to 0.64 in 2025, then sank by 98.86% to 0.01 in 2026.
• Business Quant data shows GLUE's Asset Utilization Ratio at 0.01 in Q1 2026, 0.64 in Q4 2025, and 0.37 in Q3 2025.